化学
核仁素
癌症研究
乳腺癌
细胞凋亡
结构-活动关系
癌症
人体乳房
铅化合物
生存素
天然化合物
癌细胞
计算生物学
细胞培养
细胞生长
癌症治疗
戒指(化学)
治疗方法
选择性
药理学
残留物(化学)
作者
Lizhi Gong,Jie Yang,Jiacheng Guo,Zhen Gao,Ning Gao,Yuzhen Wu,Pengyu Xiong,Xiujuan Xin,Baoli Li,Jian Li,Jinlian Wei,Faliang An
标识
DOI:10.1021/acs.jmedchem.6c00021
摘要
Triple-negative breast cancer (TNBC) remains a major clinical challenge due to its aggressive behavior, high metastatic potential, and limited therapeutic options, as current treatments often constrained by resistance and toxicity. Here, ten structurally distinct macrocyclic alkaloids were discovered from Didymella sp. Compounds 1 and 2 possessed the 13-membered macrocyclic ring alongside the novel spiro junction at C-3/C-18. Among them, phomapyrrolidone A (Ppd A) was the most active compound in the series, showing the lowest IC 50 values and favorable selectivity toward TNBC cells. Integrated proteomic profiling, bioinformatic analysis, and clinical tissue validation converged on nucleolin (NCL) as a direct and functionally relevant target. Mechanistically, Ppd A binds to the Gln558 residue of NCL, disrupts the NCL-EGFR complex, and suppresses EGFR-PI3K-AKT signaling, leading to apoptosis and tumor growth inhibition. These findings establish NCL as a promising therapeutic target and highlight hirsutellone-type alkaloids as a novel class of NCL modulators for TNBC treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI